What Is the Optimal Bowel Preparation for Capsule Colonoscopy and Pan-intestinal Capsule Endoscopy? A Systematic Review and Meta-Analysis
Background The rate of adequate cleansing (ACR) and complete examinations (CR) are key quality indicators in capsule colonoscopy (CC) and pan-intestinal capsule endoscopy (PCE). Aims To evaluate the efficacy of bowel preparation protocols regarding ACR and CR. Methods We conducted a systematic revie...
Gespeichert in:
Veröffentlicht in: | Digestive diseases and sciences 2023-12, Vol.68 (12), p.4418-4431 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background
The rate of adequate cleansing (ACR) and complete examinations (CR) are key quality indicators in capsule colonoscopy (CC) and pan-intestinal capsule endoscopy (PCE).
Aims
To evaluate the efficacy of bowel preparation protocols regarding ACR and CR.
Methods
We conducted a systematic review and meta-analysis, search terms regarding colon capsule preparation, publication date from 2006/01, and date of search 2021/12, in six bibliographic databases. Multiple steps of the cleansing protocol were assessed: diet, adjunctive laxatives, purgative solution, use of prokinetic agents, and “booster”. The meta-analytical frequency of ACR and CR was estimated, and subgroup analyses performed. Strategies associated with higher ACR and CR were explored using meta-analytical univariable and multivariable regression models.
Results
Twenty-six observational studies and five RCTs included (
n
= 4072 patients). The pooled rate of ACR was 72.5% (95% C.I. 67.8–77.5%;
I
2
= 92.4%), and the pooled rate of CR was 83.0% (95% C.I. 78.7–87.7%;
I
2
= 96.5%). The highest ACR were obtained using a low-fibre diet [78.5% (95% C.I. 72.0–85.6%);
I
2
= 57.0%], adjunctive laxatives [74.7% (95% C.I. 69.8–80.1%);
I
2
= 85.3%], and split dose |
---|---|
ISSN: | 0163-2116 1573-2568 |
DOI: | 10.1007/s10620-023-08133-7 |